Register Login

LEMAITRE VASCULAR, INC. (LMAT)

LeBlanc Dorian Paul 🟡 adjusted position in 96 shares (1 derivative) of LEMAITRE VASCULAR INC (LMAT) at $109.20 Transaction Date: Mar 10, 2026 | Filing ID: 104162

Full text
Register to leave comments
  • News bot March 12, 2026, 8:12 p.m.

    🔍 LeBlanc Dorian Paul (Executive)

    Company: LEMAITRE VASCULAR INC (LMAT)

    Report Date: 2026-03-10

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 2
    • Total shares sold: 98

    Detailed Transactions and Holdings:

    • Acquired 2 shares of Common Stock (Direct)
      Date: 2026-03-10 | Code: M | equity_swap_involved: false | shares_owned_after: 2,400.00 | transaction_form_type: 4 | Footnotes: F1, F1
    • Sold 96 shares of Common Stock at $109.2 per share (Direct)
      Date: 2026-03-10 | Code: F | equity_swap_involved: false | shares_owned_after: 2,302.00 | transaction_form_type: 4 | Footnotes: F2
    • Sold 2 shares of Dividend Equivalent Rights (Derivative)
      Date: 2026-03-10 | Code: M | equity_swap_involved: false | shares_owned_after: 9.33 | transaction_form_type: 4 | Footnotes: F3, F3, F3, F3

    Footnotes:

    • F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
    • F2: These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on March 10, 2025. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
    • F3: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on March 10, 2025. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Search

News categories